Denmark· DK-28104786610
Elidel
A pimecrolimus product containing pimecrolimus, registered in Denmark by Orifarm A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Pimecrolimus is registered in 13 of 19 countries.
Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Pimecrolimus · ATC D11AH02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Pimecrolimus
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- D11AH02
- ATC class
- Pimecrolimus
- Defined daily dose
- 20 mg, T
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104786610
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for pimecrolimus.
Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pimecrolimus · interactions on record
217 records
- 9 moderate
- 83 minor
- 125 info
Most severe, free to view
- FostamatinibB02BX09moderate
- EchinaceaD03AH02moderate
- TemsirolimusL01EG01moderate
- SirolimusL01EG04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D11AH02
Pimecrolimus, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8578cde-3872-41f9-a2d9-27094fc75c52 GET /v1/drugs/e8578cde-3872-41f9-a2d9-27094fc75c52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "creme",
"source": "dkma",
"strength": "1 %",
"auth_role": "DKMA",
"dk_drugid": "28104786610",
"substance": "Pimecrolimus",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "40535"
}See everything about pimecrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.